Effect of adipose-derived mesenchymal stromal/stem cells on mouse mammary tumour growth and formation of lung metastases
Current Research in Translational Medicine · 2025
DOI: 10.1016/j.retram.2025.103532 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Research in Translational Medicine, 2025. Verfasst von Kimberly T Peta und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Cellular and Molecular Medicine, Department of Immunology, and SAMRC Extramural Unit for Stem Cell Research and Therapy, Faculty of Hea…. Hauptthemen laut MEDLINE: Lung Neoplasms, Mesenchymal Stem Cells, Mesenchymal Stem Cell Transplantation, Adipose Tissue. Die Arbeit nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: South African Medical Research Council.
Abstract (Originalsprache)
BACKGROUND: The role of mesenchymal stromal/stem cells (MSCs) in tumour development and progression remains a subject of debate. Previous studies have reported contradictory outcomes, possibly due to variations in experimental design and the use of xenograft models. Xenograft models limit interpretation and translation due to cross-species variability. To address these limitations, we employed an isogenic mouse model of spontaneous breast cancer (BC) to investigate the impact of murine MSCs on BC development and progression. METHODS: MSCs isolated from FVB/N mouse adipose tissue (mASCs) were administered to female mice with palpable mammary tumours. Tumour volume and mass were assessed, and analysis of histopathological necrosis and gene expression was conducted on mammary (MT) and lung metastatic tumours (LT). RESULTS: No change in MT mass and volume was observed between mASC-treated and control mice. However, mASC treatment led to increased necrosis in LT but not in MT. Immunohistochemistry revealed that mASC-treated mice had fewer CD163+ anti-inflammatory macrophages in the LT but not in the MT. Tgf-β3, vegfr1, and cd105 were observed and downregulated in both MT and LT in mASC-treated mice. The downregulation of cd36 and tgf-β3 contributes to pro-tumourigenic activities, whereas the downregulation of vegfr1 and cd105 is associated with an anti-tumour effect. In the mASC treatment group, all cytokines tested for, except IL-27, were elevated. CONCLUSION: This study suggests that mASCs are anti-tumourigenic in pulmonary metastatic BC. Our findings emphasize the importance of considering the tumour microenvironment and employing relevant animal models when investigating the impact of MSCs on tumour progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Cellular and Molecular Medicine, Department of Immunology, and SAMRC Extramural Unit for Stem Cell Research and Therapy, Faculty of Health Sciences, University of Pretoria, Gezina, Pretoria, 0084, South Af…
- Department of Oral and Maxillofacial Pathology, School of Dentistry, Faculty of Health Sciences, University of Pretoria, PO Box 1266, Pretoria 0001, South Africa.
Förderung
- South African Medical Research Council
Zitieren
APA
Peta, K. T., Durandt, C., van Heerden, M. B., Pepper, M. S., & Ambele, M. A. (2025). Effect of adipose-derived mesenchymal stromal/stem cells on mouse mammary tumour growth and formation of lung metastases. Current Research in Translational Medicine. https://doi.org/10.1016/j.retram.2025.103532
Vancouver
Peta KT, Durandt C, van Heerden MB, Pepper MS, Ambele MA. Effect of adipose-derived mesenchymal stromal/stem cells on mouse mammary tumour growth and formation of lung metastases. Current Research in Translational Medicine. 2025. doi:10.1016/j.retram.2025.103532
BibTeX
@article{Peta2025,
author = {Peta, Kimberly T and Durandt, Chrisna and van Heerden, Marlene B and Pepper, Michael S and Ambele, Melvin A},
title = {Effect of adipose-derived mesenchymal stromal/stem cells on mouse mammary tumour growth and formation of lung metastases},
journal = {Current Research in Translational Medicine},
year = {2025},
doi = {10.1016/j.retram.2025.103532}
}
EUVIMED